Related Experiment Video

Updated: Jun 9, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic

William E Boden1, Gregory S Cherr, Kim A Eagle

  • 1Department of Cardiology, Buffalo General and Millard Fillmore Hospitals and Division of Cardiovascular Medicine, Schools of Medicine & Public Health, State University of New York at Buffalo, NY, USA. wboden@kaleidahealth.org

Critical Pathways in Cardiology
|August 31, 2010
PubMed

Insights

Prior cardiovascular interventions did not increase long-term adverse events in atherothrombosis patients. However, patients without prior interventions showed undertreatment of risk factors, highlighting a need for improved management strategies.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Clinical Outcomes Research

Background:

  • Atherothrombosis poses significant long-term clinical challenges.
  • Prior cardiovascular interventions aim to mitigate risks but their long-term impact on outcomes requires assessment.
  • Understanding treatment patterns and outcomes in patients with and without prior interventions is crucial for optimizing care.

Purpose of the Study:

  • To evaluate the association between prior cardiovascular interventions and long-term clinical outcomes in patients with symptomatic atherothrombosis.
  • To compare risk factor profiles and treatment patterns between patients with and without prior cardiovascular interventions.
  • To identify potential gaps in risk factor management in undertreated patient populations.

Main Methods:

  • Analysis of data from the US REACH (REduction of Atherothrombosis for Continued Health) Registry.
  • Comparison of 24-month outcomes for patients with and without prior cardiovascular interventions (catheter-based, surgical, lower-limb amputation).
  • Assessment of risk factor profiles and medication use (antihypertensive, antithrombotic, lipid-lowering therapies).

Main Results:

  • A significant proportion of US REACH Registry patients (68.1%) had prior cardiovascular interventions.
  • Patients with prior interventions were more likely to receive guideline-recommended therapies.
  • Kaplan-Meier event rates for major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke) at 24 months were similar between groups (9.10% vs. 9.00%, P=0.49).

Conclusions:

  • Prior cardiovascular intervention was not associated with an increased risk of subsequent cardiovascular ischemic events in this cohort.
  • Patients without prior interventions exhibited lower intensity of risk factor modification, suggesting they are an undertreated population.
  • Optimizing risk factor management in patients without prior interventions is essential for improving long-term clinical outcomes in atherothrombosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...